Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. May 21, 2014; 20(19): 5760-5772
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5760
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5760
Table 1 Incidence of hepatotoxicity of isoniazid and rifampicin individually, and in combination[49]
| Drugs used | Total no. of patients | Patients with hepatotoxicity | Incidence of hepatotoxicity |
| INH | 38257 | 210 | 0.6% |
| RIF | NA | NA | NA |
| INH + RIF | 6155 | 168 | 2.73% |
| INH + other drugs | 2053 | 33 | 1.6% |
| RIF + other drugs | 1264 | 14 | 1.1% |
- Citation: Kumar N, Kedarisetty CK, Kumar S, Khillan V, Sarin SK. Antitubercular therapy in patients with cirrhosis: Challenges and options. World J Gastroenterol 2014; 20(19): 5760-5772
- URL: https://www.wjgnet.com/1007-9327/full/v20/i19/5760.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i19.5760